• Azithromycin: An Assay-First Research Framework

  2026-09-17

  Azithromycin is a macrolide antibiotic with applications spanning bacterial infection research, resistance profiling, and exploratory senolytic assays. This assay-first framework explains how to connect ribosomal target engagement with orthogonal cellular readouts while avoiding unsupported cross-domain conclusions.

• X-Gal as a Decision Tool for Molecular Biology

  2026-09-16

  X-Gal is more than a blue-white colony screening reagent: it is an evidence layer for construct triage and reporter validation. This article connects its chemistry and lacZα complementation logic with assay decisions inspired by recent iRhom2 olfaction research.

• Azithromycin: Mechanism, Benchmarks, and Workflows

  2026-09-16

  Azithromycin is a macrolide antibiotic and bacterial protein synthesis inhibitor used in bacterial infection research and antimicrobial resistance studies. Its 23S rRNA binding mechanism is well established, while peptide-specific MIC data, trypanosomosis animal-model findings, and formulation properties require condition-specific interpretation.

• Bestatin (Ubenimex): Reliable Cell Assays

  2026-09-15

  A scenario-based guide to using Bestatin (Ubenimex), SKU A2575, in viability, apoptosis, aminopeptidase activity, and multidrug resistance workflows. It connects biochemical selectivity with practical solvent, dosing, control, and vendor-selection decisions.

• AO/PI Staining Solution for Reliable Cell Counting

  2026-09-14

  AO/PI Staining Solution uses two fluorescent DNA dyes to distinguish membrane-intact and membrane-compromised cells during fluorescence-based cell counting. The dual-stain format supports a fluorescent cell viability assay that can reduce interference from debris and residual red blood cells when validated with the intended instrument.

• Cefepime (BMY-28142) Research Workflows

  2026-09-14

  Build reproducible Cefepime assays for bacterial infection models, central nervous system infection research, and resistance dynamics. This guide combines fresh-solution handling, time-kill design, PKPD-informed sampling, and neurotoxicity-aware troubleshooting.

• Solanesol B8776: Practical Workflow Guide

  2026-09-13

  Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, cell-based, and enzyme workflows. Its insolubility in water and ethanol requires DMSO-based preparation, fresh-solution handling, and solvent-matched controls; it is intended for research use only and not for diagnostic or medical applications.

• X-Gal Workflow for Blue-White Colony Screening

  2026-09-12

  Build a more reliable blue-white colony screening workflow with practical guidance on stock preparation, plating, readout, and troubleshooting. This article also shows how X-Gal-based clone triage can support complex recombinant DNA technology projects while keeping functional validation separate from visual selection.

• Novobiocin: A Translational Map for Antimicrobial Research

  2026-09-11

  A mechanistically grounded guide to positioning Novobiocin across antibacterial, antiparasitic, and antiviral research while separating target engagement, cellular phenotype, exposure, and translational maturity.

• Amitriptyline HCl: Protocol and QC Guide

  2026-09-11

  Amitriptyline HCl (SKU B2231) provides a defined small-molecule reference for receptor-inhibition profiling and related neuropharmacology research workflows. This guide covers dossier-based handling, solution preparation, QC, and interpretation boundaries; it should not be treated as evidence of efficacy in clinical studies or as a substitute for assay-specific validation.

• Carbapenemase Gene Transmission in CREC Hospitals

  2026-09-10

  This 2025 BMC Microbiology study maps carbapenemase-encoding genes, their genomic location, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its combination of plasmid analysis, conjugation testing, antimicrobial susceptibility profiling, and ERIC-PCR shows how blaNDM-1-associated resistance can spread through both mobile elements and related clinical lineages.

• EPZ5676: A Selective DOT1L Inhibitor Workflow

  2026-09-10

  EPZ5676 combines subnanomolar biochemical potency with strong selectivity, making it useful for connecting DOT1L target engagement to H3K79 methylation, gene expression, and leukemia-cell phenotypes. This workflow also adapts emerging multiple myeloma findings to test innate immune signaling and lenalidomide response in a controlled research setting.

• BMS-777607 for MET and Platelet Research

  2026-09-09

  BMS-777607 provides a practical ATP-competitive probe for MET-family signaling, from c-Met phosphorylation assays to cancer metastasis models. Its most disciplined cross-domain use is as an exploratory perturbation alongside, not instead of, validated hiPSC platelet-differentiation conditions.

• NETs in CML and Differential TKI Effects

  2026-09-09

  The reference study identifies increased neutrophil extracellular trap formation as a feature of chronic myeloid leukemia and shows that tyrosine kinase inhibitors do not affect this response uniformly. Its combination of patient-derived neutrophils, a BCR-ABL1-transduced differentiation model, and pathway-directed inhibitors provides a useful framework for investigating links between kinase therapy, inflammation, and vascular toxicity.

• Otilonium Bromide: From Target to Assay Design

  2026-09-08

  Otilonium Bromide is an antimuscarinic agent for dissecting cholinergic signaling in neuronal and smooth-muscle models. This article connects receptor pharmacology, assay architecture, product handling, and lessons from structure-based inhibitor screening without overstating translational evidence.

8018 records 1/535 page Next 12345 下5页 Last page